Genetic Technologies Ltd (GENE) — Strategic Asset Allocation Index
Genetic Technologies Ltd (GENE) has a Strategic Asset Allocation Index of 5.4% as of June 2023. Strategic assets (PP&E of $599.18K plus long-term investments of $-) total $599.18K, measured against net assets of $11.16 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Genetic Technologies Ltd Strategic Asset Allocation Index (2003–2023)
This chart shows how Genetic Technologies Ltd's Strategic Asset Allocation Index has evolved across 21 annual periods from 2003 to 2023. As of June 2023, the index stands at 5.4%, representing strategic assets of $599.18K against net assets of $11.16 Million USD. Explore how efficiently does Genetic Technologies Ltd generate cash to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Genetic Technologies Ltd (2003–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Genetic Technologies Ltd from 2003 to 2023, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Genetic Technologies Ltd (GENE) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 5.4% | $599.18K | $599.18K | $- | $11.16 Million | ▼ -0.4 pp |
| 2022 | 5.8% | $953.33K | $953.33K | $- | $16.43 Million | ▲ +2.8 pp |
| 2021 | 3.0% | $637.71K | $637.71K | $- | $21.53 Million | ▼ -0.2 pp |
| 2020 | 3.1% | $440.23K | $440.23K | $- | $13.99 Million | ▼ -0.8 pp |
| 2019 | 3.9% | $69.33K | $69.33K | $0.00 | $1.77 Million | ▲ +0.2 pp |
| 2018 | 3.7% | $175.28K | $175.28K | $0.00 | $4.71 Million | ▼ -0.8 pp |
| 2017 | 4.5% | $476.65K | $476.65K | $0.00 | $10.58 Million | ▼ -0.1 pp |
| 2016 | 4.6% | $550.14K | $550.14K | $0.00 | $11.88 Million | ▲ +2.9 pp |
| 2015 | 1.7% | $321.90K | $321.90K | $0.00 | $18.96 Million | ▼ -15.3 pp |
| 2014 | 17.0% | $311.32K | $311.32K | $0.00 | $1.83 Million | ▲ +10.3 pp |
| 2013 | 6.7% | $388.00K | $388.00K | $- | $5.76 Million | ▲ +2.2 pp |
| 2012 | 4.6% | $658.00K | $658.00K | $- | $14.40 Million | ▼ -10.4 pp |
| 2011 | 14.9% | $1.02 Million | $1.02 Million | $- | $6.81 Million | ▼ -14.4 pp |
| 2010 | 29.3% | $1.68 Million | $1.68 Million | $- | $5.72 Million | ▲ +15.4 pp |
| 2009 | 13.9% | $2.42 Million | $2.42 Million | $- | $17.49 Million | ▲ +6.0 pp |
| 2008 | 7.8% | $1.63 Million | $1.63 Million | $- | $20.83 Million | ▼ -1.9 pp |
| 2007 | 9.8% | $1.65 Million | $1.65 Million | $- | $16.90 Million | ▲ +0.6 pp |
| 2006 | 9.2% | $1.68 Million | $1.68 Million | $- | $18.27 Million | ▲ +0.5 pp |
| 2005 | 8.7% | $1.99 Million | $1.99 Million | $- | $22.75 Million | ▲ +1.2 pp |
| 2004 | 7.5% | $1.29 Million | $1.29 Million | $- | $17.07 Million | ▲ +3.9 pp |
| 2003 | 3.7% | $999.00K | $999.00K | $- | $27.28 Million | — |